# Step 80: PC08.02 Evidence Closure and Next Gap

Date: 2026-10-11. Documentation-only assessment using the user's Step 80 confirmation and existing [Step 77](111-step77-pc08-02-note-contribution-identity.md), [Step 78](112-step78-pc08-02-evidence-closure-next-gap.md), [Step 79](113-step79a-pc08-02-whole-section-attribution-assessment.md) and [Step 76 inventory/conventions](110-step76-pc08-04-evidence-closure-next-gap.md). No verification was rerun.

**PC08.02 — SATISFIED — VERIFIED, with documented qualifications (outcome A).** New shared-note coverage is supported by implementation, automated evidence and the ten user-confirmed manual outcomes below. This is an internal evidence classification, not OntarioMD certification acceptance. Outstanding inventory: **13 mandatory IDs / four original packages**.

## Git checkpoint

Actual starting branch: `main`; working tree: clean. HEAD: `1056e27a11254d14297fd13f2caa827a8e745c40`, `step79 pc08-02 shared note scope closure`. The supplied `feature/step-79-pc08-02-shared-note-scope-closure` is the historical implementation branch, not the current branch. Earlier reports' uncommitted-work and outstanding-check statements remain historical; this report records the newer evidence without rewriting them.

## Implementation and reused automated evidence

Step 77 records additive migration **0071-encounter-contribution-identity**: stable contribution blocks, server-derived original identity/time and immutable revision actors. Step 79B records additive migration **0072-encounter-field-attribution**: field-linked narrative, typed-value provenance, atomic content/provenance/audit/history persistence, parent RowVersion checks and legacy replacement guards. Historical unattributed content and prior typed values are preserved without invented authorship. Signing, separate addenda and saved print/PDF output retain attribution and signed-record protections.

Step 80's user confirmation establishes that 0072 was applied to the intended **test tenant databases**, superseding Step 79B's earlier application-database deployment caveat for those databases only. No production rollout or independently observed migration execution is claimed.

| Historical verification | Recorded result |
| --- | --- |
| Step 77 contribution / relevant regression | 24 / 167 passed, respectively; regression includes focused checks |
| Step 77 draft / signing-message follow-ups | 45 / 32 passed, respectively |
| Step 79B focused checks | 45 passed / 0 failed / 0 skipped, including 11 SQL tests |
| Step 79B relevant regression | 164 passed / 0 failed / 0 skipped, including focused checks and 21 SQL tests total |
| Step 79B solution build / full TypeScript | Passed; solution build had 0 warnings / 0 errors |
| Step 79B required-field guidance follow-up | 34 passed / 0 failed / 0 skipped; affected projects compiled and full TypeScript passed |

These overlapping runs are not summed. Earlier failed attempts, corrections and narrower follow-up coverage remain recorded in their source reports. The solution/SQL regression was not rerun for the guidance follow-up; nothing was rerun during Step 80.

## Exact user-confirmed manual outcomes

These are supplied results, not checks performed by Codex. **Exactly 10 PASS and one DEFERRED group:**

| # | Outcome | Scenario |
| --- | --- | --- |
| 1 | PASS | Migration 0072 applied to intended test tenant databases. |
| 2 | PASS | Clinician A creates a template field with correct identity/timestamp. |
| 3 | PASS | Clinician B edits A's field; original authorship and revision actor preserved. |
| 4 | PASS | B edits another field; unchanged fields retain attribution. |
| 5 | PASS | Save/reopen preserves content, authorship and revisions. |
| 6 | PASS | Legacy SOAP/free-text remains readable; whole-section replacement rejected. |
| 7 | PASS | Required-field validation and structured workflows preserved. |
| 8 | PASS | Stale RowVersion save rejected; recovery preserves content. |
| 9 | PASS | Signing/addenda preserve attribution and signed-note protection. |
| 10 | PASS | Print/PDF preserves content and attribution without duplication. |
| 11 | DEFERRED | Runtime unauthorized, cross-patient, cross-tenant and forged-identity attempts. |

Item 8 supplies the previously deferred stale-save recovery evidence; the other Step 77/78 live security scenarios remain deferred within item 11. No automatic unsaved-draft restoration, exhaustive template coverage or separate deployed amendment scenario is inferred from these confirmations.

## Scope decision and certification qualifications

The established Version 1.7 Final page 30 wording requires automatic EMR user identification in each part of shared encounter documentation; manually entered identity, user-led version comparison and audit lookup are insufficient substitutes. The recorded wording permits retrievable in-note identification. It does not prescribe database-field or paragraph granularity or independently mandate printed attribution.

The Step 78 blocker was **current unattributed authoring**, not simply unknown historical identity. Step 79B closes that engineering gap: new narrative uses attributed blocks, new typed template values use field provenance, and raw SOAP/free-text or narrative-baseline replacement writes are rejected in Application and SQL. Original authors and later revision actors remain distinct and directly available within the note. Historical/default/generated content is preserved and labelled without assigning it to today's clinician; projections do not become independently authored copies. The supplied outcomes verify the new field workflow, replacement protection, persistence, validation, concurrency, signing and output.

**Outcome A is defensible under the existing qualified evidence convention.** Step 76 and Step 78 explicitly permit SATISFIED — VERIFIED with deferred live security checks when no unsupported mandatory functional element remains. Unlike Step 78, no new-content coverage hole remains identified in these supported encounter paths. This classification does not declare an authoritative exemption for unattributed current editing.

Retain OntarioMD's external interpretation of “each part,” historical/generated-content treatment, and the Baseline 5.5 folder / Version 1.7 document / tracked-release qualification. The available specification and functional evidence support this internal closure, but do not establish external certification acceptance. Retain Step 77/78 tenant routing, patient/encounter ownership, permissions, trusted actor, audit and signed-history controls and their live verification limits. Automated denial/isolation/spoofing checks do not turn item 11 into a manual PASS or prove production OAuth/OIDC and deployment configuration. No exhaustive real-record, layout or amendment acceptance is asserted.

## Inventory and preserved statuses

Recalculate from Step 76's actual package table; only PC08.02 is removed:

| Remaining original package | Outstanding mandatory IDs |
| --- | --- |
| Referral letter content/evidence | PC10.01 |
| Medication/prescribing | PC04.01, PC04.05, PC04.06, PC04.07, PC04.09, PC04.14, PC04.16 |
| CPP | PC07.01, PC07.04, PC07.07, PC07.10 |
| Scheduling | PC09.03 |

**14 → 13 unique mandatory IDs; five → four original packages.** Arithmetic: 1 PC10 + 7 PC04 + 4 PC07 + 1 PC09 = 13. Note contribution identity contained only PC08.02, so it becomes empty. Deferred supporting checks are not new IDs/packages; separate PC10.02 verification does not inflate this established inventory.

Preserve **PC10.01 — PARTIAL — IMPLEMENTED, VERIFICATION OUTSTANDING**, including its verified alternative-contact sub-gap, and **PC10.02 — IMPLEMENTED — NEEDS MANUAL VERIFICATION**. PC08.04, PC08.06, PC09.06 and PC09.12 retain their prior statuses and security qualifications. All other historical decisions and dictionary/supplier/billing dependencies remain unchanged.

## Next mandatory target and execution boundary

Select **PC10.01 — referral letter evidence closure**, as a verification target, not a declaration of implementation readiness. Reuse its existing implementation/evidence to obtain realistic multi-user selected/excluded clinical-content verification, preserved historical artifact comparisons and recorded permission/patient/tenant/read-audit/output checks. Reconcile those outcomes before deciding closure; do not infer referral acceptance from encounter-note tests. PC10.02 remains separately outstanding. No independent implementation-ready candidate is established by Step 76's bounded comparison; prescribing/CPP dictionary/supplier and PC09.03 billing-contract blockers persist.

Suggested next branch: `feature/step-81-pc10-01-referral-letter-evidence-closure` — proposal only, not created or started.

Only this report is created. Documentation checks cover source links, exact manual transcription, status rationale, package arithmetic, whitespace and final Git change scope. No application changes, tests, builds, migrations, database/browser operations, new standards retrieval, staging, commit, merge, branch switch/creation, reset or discard. Stop after this documentation checkpoint.
